Patient Care Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Patient Care Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Keio University, Japan

Journal articles summarize Keio University, Japan, study findings

This trend article about Keio University, Japan, is an immediate alert from NewsRx to identify developing directions of research.

Study 1: Researchers detail in "Population pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureus," new data in chemotherapy. According to recent research published in the journal Antimicrobial Agents and Chemotherapy, "Arbekacin, a derivative of dibekacin, is an aminoglycoside developed and widely used in Japan for the treatment of patients infected with methicillin-resistant Staphylococcus aureus...

• View Other Issues of Patient Care Law Weekly
  
• View Other NewsRx Publications